These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38462608)

  • 1. ANGPTL3 is a novel HDL component that regulates HDL function.
    Yang L; Wang Y; Xu Y; Li K; Yin R; Zhang L; Wang D; Wei L; Lang J; Cheng Y; Wang L; Ke J; Zhao D
    J Transl Med; 2024 Mar; 22(1):263. PubMed ID: 38462608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients.
    Zhao D; Yang LY; Wang XH; Yuan SS; Yu CG; Wang ZW; Lang JN; Feng YM
    Cardiovasc Diabetol; 2016 Sep; 15(1):132. PubMed ID: 27620179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANGPTL3 (Angiopoietin-Like 3) Preferentially Resides on High-Density Lipoprotein in the Human Circulation, Affecting Its Activity.
    Kraaijenhof JM; Tromp TR; Nurmohamed NS; Reeskamp LF; Langenkamp M; Levels JHM; Boekholdt SM; Wareham NJ; Hoekstra M; Stroes ESG; Hovingh GK; Grefhorst A
    J Am Heart Assoc; 2023 Nov; 12(21):e030476. PubMed ID: 37889183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Insights of ANGPTL-3 on Modulating Cholesterol Efflux Capacity Induced by HDL Particle.
    Lai M; Jiang X; Wang B; Cheng Y; Su X
    Curr Mol Med; 2024; 24(6):771-779. PubMed ID: 37073658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiopoietin-Like Protein 4 Is a High-Density Lipoprotein (HDL) Component for HDL Metabolism and Function in Nondiabetic Participants and Type-2 Diabetic Patients.
    Yang LY; Yu CG; Wang XH; Yuan SS; Zhang LJ; Lang JN; Zhao D; Feng YM
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol.
    Xu YX; Redon V; Yu H; Querbes W; Pirruccello J; Liebow A; Deik A; Trindade K; Wang X; Musunuru K; Clish CB; Cowan C; Fizgerald K; Rader D; Kathiresan S
    Atherosclerosis; 2018 Jan; 268():196-206. PubMed ID: 29183623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3.
    Pisciotta L; Favari E; Magnolo L; Simonelli S; Adorni MP; Sallo R; Fancello T; Zavaroni I; Ardigò D; Bernini F; Calabresi L; Franceschini G; Tarugi P; Calandra S; Bertolini S
    Circ Cardiovasc Genet; 2012 Feb; 5(1):42-50. PubMed ID: 22062970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential association of plasma angiopoietin-like proteins 3 and 4 with lipid and metabolic traits.
    Mehta N; Qamar A; Qu L; Qasim AN; Mehta NN; Reilly MP; Rader DJ
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1057-63. PubMed ID: 24626437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Canagliflozin on High-Density Lipoprotein Cholesterol and Angiopoietin-Like Protein 3 in Type 2 Diabetes Mellitus.
    Liu S; Ke J; Feng X; Wang Z; Wang X; Yang L; Zhao D
    J Diabetes Res; 2024; 2024():2431441. PubMed ID: 38577301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8.
    Sylvers-Davie KL; Segura-Roman A; Salvi AM; Schache KJ; Davies BSJ
    J Lipid Res; 2021; 62():100112. PubMed ID: 34461133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically determined deficiency of ANGPTL3 does not alter HDL ability to preserve endothelial homeostasis.
    Ossoli A; Minicocci I; Turri M; Di Costanzo A; D'Erasmo L; Bini S; Montavoci L; Veglia F; Calabresi L; Arca M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Mar; 1868(3):159263. PubMed ID: 36521735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-density lipoprotein of patients with breast cancer complicated with type 2 diabetes mellitus promotes cancer cells adhesion to vascular endothelium via ICAM-1 and VCAM-1 upregulation.
    Huang X; He D; Ming J; He Y; Zhou C; Ren H; He X; Wang C; Jin J; Ji L; Willard B; Pan B; Zheng L
    Breast Cancer Res Treat; 2016 Feb; 155(3):441-55. PubMed ID: 26872904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense oligonucleotide-mediated inhibition of angiopoietin-like protein 3 increases reverse cholesterol transport in mice.
    Bell TA; Liu M; Donner AJ; Lee RG; Mullick AE; Crooke RM
    J Lipid Res; 2021; 62():100101. PubMed ID: 34371033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal HDL Cholesterol Efflux and Anti-Inflammatory Capacities in Type 2 Diabetes Despite Lipidomic Abnormalities.
    Denimal D; Benanaya S; Monier S; Simoneau I; Pais de Barros JP; Le Goff W; Bouillet B; Vergès B; Duvillard L
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3816-e3823. PubMed ID: 35647758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase.
    Shimamura M; Matsuda M; Yasumo H; Okazaki M; Fujimoto K; Kono K; Shimizugawa T; Ando Y; Koishi R; Kohama T; Sakai N; Kotani K; Komuro R; Ishida T; Hirata K; Yamashita S; Furukawa H; Shimomura I
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):366-72. PubMed ID: 17110602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between Serum Angiopoietin-like Proteins 3 and 8 and Atherogenic Lipid Biomarkers in Non-Diabetic Adults Depends on Gender and Obesity.
    Murawska K; Krintus M; Kuligowska-Prusinska M; Szternel L; Stefanska A; Sypniewska G
    Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANGPTL3 is part of the machinery causing dyslipidemia majorily via LPL inhibition in mastitis mice.
    Xiao HB; Wang JY; Sun ZL
    Exp Mol Pathol; 2017 Dec; 103(3):242-248. PubMed ID: 29104012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serum levels of angiopoietin-like protein 3 and 4 in type 2 diabetic patients with and without metabolic syndrome compared to the control group.
    Hezarkhani S; Hajighaderi A; Hosseinzadeh S; Behnampour N; Veghari G; Fathabadi F; Hesari Z; Joshaghani HR
    Endocrinol Diabetes Metab; 2024 Jan; 7(1):e466. PubMed ID: 38140923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70.
    Bergmark BA; Marston NA; Bramson CR; Curto M; Ramos V; Jevne A; Kuder JF; Park JG; Murphy SA; Verma S; Wojakowski W; Terra SG; Sabatine MS; Wiviott SD;
    Circulation; 2022 May; 145(18):1377-1386. PubMed ID: 35369705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Citrus Flavonoid Nobiletin Downregulates Angiopoietin-like Protein 3 (ANGPTL3) Expression and Exhibits Lipid-Modulating Effects in Hepatic Cells and Adult Zebrafish Models.
    Lin CY; Chen PY; Hsu HJ; Gao WY; Wu MJ; Yen JH
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.